Novartis AG Profile

USD 0.86  1.02%
82.88Last Month High 86.05 
83.68Trading Day  High 84.09 

Novartis AG Summary

Novartis AG (NVS) is traded on New York Stock Exchange in USA. It is located in SWITZERLAND and employs 118,000 people. Novartis AG is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 201.63 B. Novartis AG has 2.33 B outstanding shares of which 1.97 M shares are now shorted by investors with about 0.89 days to cover shorted positions. NOVARTIS AG ADS has about 9.4 B in cash with 12.8 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.59.
Check Novartis AG Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares44.6 M3.8 B
Primecap Management CoCommon Shares22 M1.9 B
View Novartis AG Diagnostics

Selected Novartis AG Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Novartis AG Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 15% 
Novartis AG researches, develops, manufactures, and markets a range of healthcare solutions worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameNovartis AG
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressBasel,
Foreign Associate  Argentina
ExchangeNew York Stock Exchange
IndustryPharmaceutical Products
Contact Number41 61 324 11 11
Related EntityNVSEF
CurrencyUSD - US Dollar


Novartis AG Analyst Recommendations
Target PriceAdvice# of Analysts
Novartis AG current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Novartis AG Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Novartis AG Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.15April 20, 2017
Novartis AG normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate